The Journal of Clinical Psychiatry
September 8, 2009
Rodrigo Machado‐Vieira, Peixiong Yuan, Nancy E. Brutsché et al.
154 citations
OBJECTIVE: A model has been proposed to explain the pathophysiology of mood disorders based on decreased neurotrophin levels during mood episodes; treatment with antidepressants and mood stabilizers is associated with clinical improvement. This study investigated whether changes in brain-derived neurotrophic factor (BDNF) levels are associated with the initial antidepressant effects of...
The Journal of Clinical Psychiatry
September 30, 2008
Michael Paulzen, Gerhard Gründer
32 citations
Article AbstractBecause this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text. Sir: The hallucinogenic sage Salvia divinorum (S.divinorum) is known by many names, including ska Maria, skaPastora, hojas de Maria, and many others. Despite its manynames, S. divinorum was not identified until 1962, whenWasson and Hofmann collected a member of the...
The Journal of Clinical Psychiatry
September 2008
James S Gordon, Julie K Staples, Afrim Blyta et al.
To determine whether participation in a mind-body skills group program based on psychological self-care, mind-body techniques, and self-expression decreases symptoms of posttraumatic stress disorder (PTSD). Eighty-two adolescents meeting criteria for PTSD according to the Harvard Trauma Questionnaire (which corresponds with 16 of the 17 diagnostic criteria for PTSD in DSM-IV) were randomly...
The Journal of Clinical Psychiatry
August 15, 2007
Lynne J. Lamarche, Joseph De Koninck
174 citations
OBJECTIVE: To present a critical review of the literature and research on sleep difficulties in adults with posttraumatic stress disorder (PTSD), more specifically the existing treatment options, and to formulate recommendations regarding future treatment approaches and research related to sleep and PTSD. DATA SOURCES: The following databases were consulted: PsycInfo (1872-2006) and MEDLINE...
The Journal of Clinical Psychiatry
November 15, 2006
Francisco Moreno, Christopher B. Wiegand, E. Keolani Taitano et al.
786 citations
In a controlled clinical environment, psilocybin was safely used in subjects with OCD and was associated with acute reductions in core OCD symptoms in several subjects.
The Journal of Clinical Psychiatry
June 15, 2005
Carl Salzman
Article AbstractBecause this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.Malcolm Bowers, Jr., a professor of psychiatry at Yale anda leading American researcher in the neurobiology of schizophrenia,has written a useful, concise historical review of the relationshipbetween illicit drugs and prescribed medication andthe development of psychosis....
The Journal of Clinical Psychiatry
October 15, 2004
Nicholas Weiss, Lee Jones, John Chamberlain
33 citations
Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.Sir: Psychosis due to sleep deprivation has been frequently reported.1 In hallucinogen use, however, the duration of sleep deprivation is usually limited to a few days, and psychosis is attributed to the direct effects of the hallucinogens on the central nervous...
The Journal of Clinical Psychiatry
October 1, 2004
A case of prolonged peyote-induced psychosis resolved by sleep.
The Journal of Clinical Psychiatry
April 1999
Maurice Ohayon, Christian Guilleminault, R G Priest
Arousal parasomnias (night terrors, sleepwalking, and confusional arousals) have seldom been investigated in the adult general population. Clinical studies of parasomnias, however, show that these disorders may be indicators of underlying mental disorders and may have serious consequences. A representative sample of the United Kingdom population (N = 4972) was interviewed by telephone with the...
The Journal of Clinical Psychiatry
April 15, 1998
Malcolm B. Bowers
10 citations
Article AbstractSir: Marijuana use has been associated with mental illness for more than a century and a half. This relationship was first noted by J. J. Moreau de Tours in his 1845 classic work, Hashish and Mental Illness. Observations by Indian psychiatrists kept the topic alive during the first half of this century.